Cross‐Species Transfer of the Maize NAM‐ATAF1/2‐CUC2 Transcription Factor ZmNAC2 Confers Disease Resistance in Transgenic Rice Without a Yield Penalty
Molecular Plant Pathology · 2026
DOI: 10.1111/mpp.70198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Plant Pathology, 2026. Verfasst von Xinying Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plant Pathology, College of Plant Protection, China Agricultural University, Beijing, China. Hauptthemen laut MEDLINE: Oryza, Zea mays, Disease Resistance, Plant Diseases. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Universities Scientific Fund, China Agricultural University.
Abstract (Originalsprache)
Rice is a staple crop feeding over half of the global population, yet it faces severe yield losses due to devastating diseases, including those caused by hemibiotrophic pathogens, such as Magnaporthe oryzae (the causative agent of blast disease) and Xanthomonas oryzae pv. oryzae (the bacterial leaf blight pathogen). While resistance genes are a cornerstone of crop protection, many nucleotide‐binding leucine‐rich receptor ( NLR )‐type resistance genes are prone to breakdown and often impose yield penalties. In this study, we report that the cross‐species transfer of the maize NAM‐ATAF1/2‐CUC2 transcription factor ZmNAC2 into rice confers resistance to both blast and bacterial leaf blight diseases without compromising yield. Mechanistically, ZmNAC2 interacts with OsNAC2, a negative regulator of salicylic acid (SA) biosynthesis, and disrupts its association with the APETALA2/ethylene‐responsive element binding protein OsEREBP1 in the OsZmNAC2 transgenic rice, thereby quenching repression and promoting SA production. Moreover, ZmNAC2 binds to the cis ‐regulatory elements within the promoter of the SA biosynthetic gene phenylalanine ammonia lyase 6 , transactivating its expression and further enhancing SA accumulation. The resulting elevated SA levels impart broad‐spectrum resistance in the transgenic rice against M. oryzae and X. oryzae pv. oryzae . Together, our findings provide a proof of concept for leveraging non‐ NLR genes from staple food crops to boost disease resistance without incurring yield penalties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Plant Pathology, College of Plant Protection, China Agricultural University, Beijing, China.
- Key Laboratory of Crop Pest Monitoring and Green Management (Ministry of Agriculture and Rural Affairs), China Agricultural University, Beijing, China.
- State Key Laboratory of Agriculture and Forestry Biosecurity, China Agricultural University, Beijing, China.
- State Key Laboratory of Maize Bio-breeding, College of Plant Protection, China Agricultural University, Beijing, China.
ORCID-Profile: You-Liang Peng, Vijai Bhadauria
Förderung
- National Natural Science Foundation of China
- Chinese Universities Scientific Fund
- China Agricultural University
Zitieren
APA
Gao, X., Yang, J., Xiong, P., Zhang, X., Liu, J., Zhao, W., Peng, Y. L., & Bhadauria, V. (2026). Cross‐Species Transfer of the Maize NAM‐ATAF1/2‐CUC2 Transcription Factor ZmNAC2 Confers Disease Resistance in Transgenic Rice Without a Yield Penalty. Molecular Plant Pathology. https://doi.org/10.1111/mpp.70198
Vancouver
Gao X, Yang J, Xiong P, Zhang X, Liu J, Zhao W, et al. Cross‐Species Transfer of the Maize NAM‐ATAF1/2‐CUC2 Transcription Factor ZmNAC2 Confers Disease Resistance in Transgenic Rice Without a Yield Penalty. Molecular Plant Pathology. 2026. doi:10.1111/mpp.70198
BibTeX
@article{Gao2026,
author = {Gao, Xinying and Yang, Jun and Xiong, Peishan and Zhang, Xin and Liu, Junfeng and Zhao, Wensheng and Peng, You-Liang and Bhadauria, Vijai},
title = {Cross‐Species Transfer of the Maize NAM‐ATAF1/2‐CUC2 Transcription Factor ZmNAC2 Confers Disease Resistance in Transgenic Rice Without a Yield Penalty},
journal = {Molecular Plant Pathology},
year = {2026},
doi = {10.1111/mpp.70198}
}
EUVIMED